Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.80
+0.07 (0.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 517 employees as of December 31, 2023. The number of employees increased by 33 or 6.82% compared to the previous year.
Employees
517
Change (1Y)
33
Growth (1Y)
6.82%
Revenue / Employee
$954,876
Profits / Employee
-$202,491
Market Cap
2.93B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
QuidelOrtho | 7,100 |
Warby Parker | 3,473 |
Zai Lab | 2,175 |
iRhythm Technologies | 2,000 |
Twist Bioscience | 923 |
Xenon Pharmaceuticals | 259 |
Merus | 229 |
FOLD News
- 3 days ago - NCLA Amicus Brief Asks Fifth Circuit to Uphold Block on Unconstitutional Corporate Transparency Act - GlobeNewsWire
- 8 days ago - Retired Judges' Amicus Brief Supports Judge Newman in NCLA Suit Against Her Suspension - GlobeNewsWire
- 8 days ago - Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday? - Benzinga
- 18 days ago - NCLA Amicus Brief Asks Fifth Circuit to Overturn Banking Administration Board's Denial of Jury Trial - GlobeNewsWire
- 5 weeks ago - NCLA Amicus Brief Asks Fifth Circuit to Overturn Currency Comptroller's Violation of Jury Trial Rights - GlobeNewsWire
- 6 weeks ago - Amicus Therapeutics, Inc. (FOLD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024 - GlobeNewsWire
- 7 weeks ago - Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024 - GlobeNewsWire